In just a few short weeks, COVID-19 has drastically altered our lives, inflicting great human suffering and upending even the most fundamental tenets of communal harmony. Beyond the immediate effects on people’s health, employment, and income, the epidemic is making individuals more anxious and worried, which has an impact on their social interactions, their level […]
Continue Reading
The US Food and Drug Administration (FDA) of the United States has approved the on-body infusor ‘Furoscix’ for congestive heart failure developed by scpharmaceuticals. With this approval, Furoscix becomes the first self-administered, and subcutaneous loop diuretic for people with worsening heart failure. This infusor delivers generic furosemide that relieves fluid retention and swelling, which causes […]
Continue Reading
The UK Health Security Agency announced that people at high risk of contracting monkeypox disease will be offered second doses of the vaccine. UKSHA said sexual health clinics will continue to prioritise offering first doses of the monkeypox vaccine to those at high risk. Some clinics will offer a second dose to the eligible people, […]
Continue Reading
Theranica, a digital therapeutics company, has conducted a study comparing the effectiveness of Remote Electrical Neuromodulation (REN) to standard-care medications for the acute treatment of chronic migraine. The study concludes that REN, administered by the flagship therapeutic wearable of Theranica, provides an effective non-pharmaceutical alternative to the standard-care abortive medications in individuals affected by chronic […]
Continue Reading